Carine Van Lint MD-PhD

biographic summary

Carine M.C. VAN LINT, PhD (Belgium)

– Research Director of the Belgian National Fund for Scientific Research (FRS-F.N.R.S., Belgium).

– Director of the Laboratory of Molecular Virology, University of Brussels (ULB), Belgium.

– Professor, Faculty of Sciences and Faculty of Medicine, University of Brussels (ULB), Belgium.

 

Biography

Carine Van Lint is Professor at the University of Brussels (ULB, Belgium) and Research Director of the Belgian National Fund for Scientific Research (F.N.R.S.). She is author and co-author of more than 90 international publications in the field of retrovirology and molecular biology. After performing her PhD thesis at the National Institutes of Health (NIH, Bethesda, USA) and a post-doctoral fellowship at the Picower Institute in New-York, she joined the Faculty of Science of the University of Brussels (ULB) as the Director of the Laboratory of Molecular Virology. Her research aims at studying the molecular and epigenetic mechanisms regulating transcriptional latency and reactivation from latency in 3 retroviruses: HIV-1 and two oncogenic retroviruses HTLV-I (human T cell leukemia/lymphoma virus type 1) and BLV (Bovine Leukemia Virus). Regarding HIV-1, one of the major objective of her laboratory is to design, based on transcriptional mechanisms, novel strategies to reduce the pool of latent reservoirs to a level bearable by the host immune system.